According to Grand View Research, the global nuclear medicine market size was an estimated 8.1 billion USD in 2021 and is expected to increase 13% from 2022-2030. Nuclear medicine is expanding quickly due to advancements in products and government initiatives that improve nuclear medicine access. There is also an increase in cancer patients that will contribute to market growth.

Radiopharmaceuticals are radioactive drugs that are made, studied, and administered in a variety of settings, including hospitals, universities, and research centres. Shielding is increasingly in demand as nuclear medicine becomes more and more common. The nuclear medicine sector has access to a wide range of shielding products.

Below are some of the common shielding products that would be used in a lab or clinic setting.

Commonly used products are tungsten vial shields for the administering of radioisotopes, while tungsten or lead storage containers are often referred to as “pigs”.

Solid tungsten is a very commonly used material because it is durable and has slightly better gamma radiation attenuation than lead. The drawback of tungsten is that it is significantly more expensive than the lead. Solid tungsten can also be made into syringe shields and vial transport containers.

Keep reading this blog on MarShield.com